The Romanian Organization for Serializing Medicines (OSMR) is a non-governmental, autonomous, independent, apolitical and non-profit organization, established for the implementation of the European Directive 2011/62/EU on falsified medicines and of the Delegated Regulation 2016/161.
OSMR is financed exclusively through the contribution of the manufacturers of medicinal products (MAH), according to the provisions of the above-mentioned Directive, based on their status as OSMR affiliated members. OSMR has not received and does not take up fees, in any form, from End Users (wholesalers, pharmacies, hospitals, persons authorized or entitled to supply medicinal products to the public) or other entities, other than MAH.
Should such requests be addressed to you, on behalf of OSMR, please urgently contact us at: firstname.lastname@example.org
The Marketing Authorisation Holders and Parallel Import Authorisation Holders connect to the European Hub via the OBP (On-Boarding Partner) and ensure that the information related to medicines with unique identifiers is uploaded to the European Hub.
This section is dedicated to the IT solutions providers whose software product (s) is (are) used in the pharma industry in locations which will act as End-Users for the NMVS (National Medicines Verification System): pharmacies, authorized medicines wholesalers’ warehouses, parallel importers’ locations, hospital pharmacies.
Updated version of NMVS
Starting with early October, the updated version of NMVS, namely NMVS CORE 1.08 will enter the production environment.
According to the ARVATO documentation, this version is no longer compatible with the V2 interface which connects the End Users’ internal software applications.
Therefore, after October 1st, the V2 interface can be disconnected at any time by Arvato without prior warning.
We come back with the request that all End-Users switch to later versions in order to avoid blocking the activity.